Sally J. Turner

My PhD research investigates the association between cannabis use and ADHD, with specific emphasis on the harms and medicinal potential of cannabis amongst adults with ADHD. My PhD adopts novel and cross-disciplinary methodology, and employs novel quantitative, qualitative, and field-based research techniques, to analyse primary and secondary data provided by recreational and medicinal cannabis users across the UK. My research addresses the ESRC’s strategic priority ‘Securing Better Health’ and extends across other areas of importance for the ESRC and MRC.

 

Publications:

1. Turner, S. J. (2022) ‘Schizophrenia and cannabis use: new evidence measures risk of relapse’, MentalElf. Available at https://www.nationalelfservice.net/mental-health/schizophrenia/schizophrenia-cannabis/
2. Turner, S. J., Slaney, C., Robinson, E. J., & Attwood, A. (2022). MSc Dissertation: An investigation of reward motivation in adults with low and high trait levels of attention-deficit hyperactivity disorder. Open Science Framework. Doi: https://osf.io/sc7gz
3. Turner, S. J. (2022) ‘Cannabis use in college: genetic predispositions less influential than social environment, Available at https://www.nationalelfservice.net/mental-health/substance-misuse/cannabis-use-in-college/
4. Turner, S. J., & Kent, C. (2022). Substance use is not associated with ADHD or reward sensitivity in young adults. Journal of Psychopharmacology, 36(8). 60-61. https://www.bap.org.uk/pdfs/2022BAPAbstractBook.pdf
5. Turner, S. J., Slaney, C., & Attwood, A. (2023). MSc Dissertation: Experience of reward in adults with attention-deficit hyperactivity disorder: a qualitative study. Open Science Framework. Doi: https://osf.io/sghu4
6. Turner, S. (2023) ‘Drugs: What are they good for? 5-MeO-DMT edition’, Drug Science. Available at https://www.drugscience.org.uk/5-meo-dmt-drugs/

Honorary Research Assistant at Drug Science (About Drug Science – drugscience.org.uk)